Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Indian workers shut lights during FDA inspection
by Jean-François Tremblay
May 22, 2017
| A version of this story appeared in
Volume 95, Issue 21
FDA warned the drug producer Vikshara Trading & Investments for obstructing an inspection of its plant in Ahmedabad in northwestern India. During the inspection last year, the company allegedly impeded FDA officials by blocking access to the vessel room as well as the packaging and labeling areas. Workers also did not turn on the lights in unlocked parts of the facility. Using a flashlight, FDA officials were, however, able to observe “powder scattered throughout the production areas, including powder caked on the floor.”
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter